Home

Terumo Corp (TRUMF)

18.98
+0.76 (4.17%)
OP · Last Trade: Jun 16th, 5:17 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close18.22
Open18.06
Bid-
Ask-
Day's Range18.06 - 19.28
52 Week Range15.00 - 22.26
Volume4,013
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume4,711

Chart

News & Press Releases

Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analystbenzinga.com
Inari Medical with strong position in venous thrombectomy. Buy-rated by Needham with a $72 target. Undervalued shares with an 88% gross margin and anticipated double-digit revenue growth.
Via Benzinga · January 23, 2024